Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Neurology
|
November 1, 1994
Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group
C Smith, G Birnbaum, J L Carter, et al.
Journal of Neuroimmunology
|
July 30, 1999
Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders
J A Cohen, J L Carter, R P Kinkel, et al.
The American Surgeon
|
July 1, 1997
Tubular carcinoma of the breast: an institutional review
M F McBoyle, H A Razek, J L Carter, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
April 20, 2001
Metachronous bilateral primary adenocarcinoma of the submandibular glands
P S Hardee, J L Carter, K M Piper, et al.
Rivista Di Neurologia
|
March 1, 1987
Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies
D M Dawson, J L Carter, D A Hafler, et al.
Mayo Clinic Proceedings
|
December 31, 1997
Management of impairment, disability, and handicap due to multiple sclerosis
K A Stolp-Smith, J L Carter, D E Rohe, et al.
The American Review of Respiratory Disease
|
June 1, 1982
Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea
W T McNicholas, J L Carter, R Rutherford, et al.
Veterinary Parasitology
|
May 2, 2002
The effect of diet fed to lambs on subsequent development of Trichostrongylus colubriformis larvae in vitro and on pasture
J H Niezen, G C Waghorn, T Graham, et al.
Neurology
|
July 1, 1988
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients
J L Carter, D A Hafler, D M Dawson, et al.
Neurology
|
June 11, 2003
MRI changes in status epilepticus
J I Sirven, R S Zimmerman, J L Carter, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Neurology
|
November 1, 1994
Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group
C Smith, G Birnbaum, J L Carter, et al.
Journal of Neuroimmunology
|
July 30, 1999
Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders
J A Cohen, J L Carter, R P Kinkel, et al.
The American Surgeon
|
July 1, 1997
Tubular carcinoma of the breast: an institutional review
M F McBoyle, H A Razek, J L Carter, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
April 20, 2001
Metachronous bilateral primary adenocarcinoma of the submandibular glands
P S Hardee, J L Carter, K M Piper, et al.
Rivista Di Neurologia
|
March 1, 1987
Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies
D M Dawson, J L Carter, D A Hafler, et al.
Mayo Clinic Proceedings
|
December 31, 1997
Management of impairment, disability, and handicap due to multiple sclerosis
K A Stolp-Smith, J L Carter, D E Rohe, et al.
The American Review of Respiratory Disease
|
June 1, 1982
Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea
W T McNicholas, J L Carter, R Rutherford, et al.
Veterinary Parasitology
|
May 2, 2002
The effect of diet fed to lambs on subsequent development of Trichostrongylus colubriformis larvae in vitro and on pasture
J H Niezen, G C Waghorn, T Graham, et al.
Neurology
|
July 1, 1988
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients
J L Carter, D A Hafler, D M Dawson, et al.
Neurology
|
June 11, 2003
MRI changes in status epilepticus
J I Sirven, R S Zimmerman, J L Carter, et al.
Page
of 6